0,985  0,002  Eye irritation, high
0,981  0,002  Skin irritative effect
0,897  0,003  GST A substrate
0,873  0,003  Cholesterol antagonist
0,843  0,005  Antihypercholesterolemic
0,827  0,003  Ulceration
0,823  0,003  Histamine release inhibitor
0,817  0,008  Teratogen
0,811  0,003  Antiseptic
0,805  0,003  Skeletal muscle relaxant
0,808  0,006  Carcinogenic
0,806  0,008  Embryotoxic
0,800  0,006  Radioprotector
0,762  0,004  Vasodilator, peripheral
0,756  0,002  Alpha-N-acetylglucosaminidase inhibitor
0,755  0,003  Glutathione S-transferase substrate
0,752  0,004  Muscle relaxant
0,736  0,002  Aldehyde dehydrogenase inhibitor
0,741  0,008  Respiratory analeptic
0,729  0,006  Aldehyde oxidase inhibitor
0,727  0,007  Sensitization
0,738  0,019  Caspase 9 stimulant
0,715  0,007  Antithrombotic
0,712  0,007  Analeptic
0,707  0,006  Spasmolytic
0,701  0,003  Antipruritic, allergic
0,705  0,009  Mutagenic
0,691  0,005  Antipyretic
0,683  0,015  TNF expression inhibitor
0,671  0,005  5 Hydroxytryptamine release inhibitor
0,635  0,006  Vasodilator, coronary
0,634  0,005  Antiglaucomic
0,626  0,003  Radiosensitizer
0,653  0,040  Antiinflammatory
0,613  0,005  Hair growth stimulant
0,611  0,003  GST P1-1 substrate
0,607  0,014  5 Hydroxytryptamine release stimulant
0,592  0,004  VCAM1 expression inhibitor
0,586  0,011  Lipoprotein disorders treatment
0,586  0,012  NOS3 expression inhibitor
0,587  0,017  Chemoprotective
0,575  0,004  Phospholipase C inhibitor
0,587  0,018  Immunostimulant
0,577  0,009  Hypoglycemic
0,595  0,028  Cyclophilin D inhibitor
0,595  0,028  Antidiabetic
0,560  0,003  Antihyperlipoproteinemic
0,570  0,018  Antiallergic
0,567  0,018  Immunosuppressant
0,549  0,003  Alcohol oxidase inhibitor
0,546  0,009  Hypolipemic
0,538  0,006  Anesthetic general
0,544  0,012  FMO1 substrate
0,541  0,010  Platelet antagonist
0,534  0,005  Anesthetic
0,527  0,002  Triose-phosphate isomerase inhibitor
0,533  0,014  Antihypertensive
0,523  0,004  Mediator release inhibitor
0,523  0,010  Vasodilator
0,515  0,005  Amylase inhibitor
0,518  0,009  UGT2B4 substrate
0,512  0,004  Protein kinase stimulant
0,527  0,019  Immunomodulator
0,510  0,008  Antiulcerative
0,507  0,009  Platelet aggregation inhibitor
0,510  0,014  Cardiodepressant
0,500  0,007  Non-steroidal antiinflammatory agent
0,495  0,004  CNS active muscle relaxant
0,510  0,025  Bone diseases treatment
0,487  0,003  Antipruritic, non-allergic
0,485  0,005  Antidote
0,490  0,011  Antihypoxic
0,482  0,004  Phospholipase A2 inhibitor
0,493  0,021  Cytostatic
0,503  0,031  Atherosclerosis treatment
0,484  0,013  Antidiabetic symptomatic
0,476  0,006  Abortion inducer
0,479  0,010  Interleukin agonist
0,488  0,020  Cardiovascular analeptic
0,477  0,012  Sedative
0,465  0,005  Insulin secretagoues
0,473  0,014  Antihypertriglyceridemic
0,467  0,009  UGT1A3 substrate
0,458  0,003  Succinate dehydrogenase inhibitor
0,469  0,016  DNA synthesis inhibitor
0,492  0,042  CYP3A4 substrate
0,452  0,008  Antiparkinsonian, rigidity relieving
0,446  0,004  Expectorant
0,445  0,004  Corneal wound healing stimulator
0,455  0,015  Psychostimulant
0,451  0,012  Wound healing agent
0,463  0,024  UGT1A9 substrate
0,461  0,028  Cardioprotectant
0,443  0,011  Cyclic AMP phosphodiesterase inhibitor
0,432  0,007  Muscular dystrophy treatment
0,453  0,029  Antipsoriatic
0,450  0,028  Antiosteoporotic
0,419  0,004  Antieczematic
0,425  0,010  Carcinogenic, group 3
0,428  0,017  Peroxidase inhibitor
0,415  0,005  DNA polymerase I inhibitor
0,412  0,003  Catalase inhibitor
0,409  0,006  Anesthetic local
0,406  0,005  Interleukin 4 antagonist
0,431  0,031  CTGF expression inhibitor
0,432  0,032  Cytotoxic
0,417  0,019  Myocardial infarction treatment
0,434  0,036  Antifungal
0,407  0,011  GST M1-1 substrate
0,396  0,002  Endocannabinoid uptake inhibitor
0,394  0,001  Antiviral (Parainfluenza)
0,394  0,003  Toll-Like receptor 2 antagonist
0,393  0,004  Antineoplastic, alkylator
0,394  0,007  Antiparkinsonian, tremor relieving
0,394  0,008  Interleukin 6 antagonist
0,398  0,013  Diuretic
0,417  0,034  Apoptosis antagonist
0,386  0,004  Alcohol dehydrogenase substrate
0,380  0,005  Gastrin inhibitor
0,391  0,017  P-glycoprotein inhibitor
0,371  0,003  Mucolytic
0,398  0,032  NOS2 expression inhibitor
0,406  0,042  Hepatic disorders treatment
0,414  0,051  Stroke treatment
0,394  0,032  Interleukin antagonist
0,401  0,040  ICAM1 expression inhibitor
0,364  0,004  Phosphofructokinase-1 inhibitor
0,399  0,040  CYP1A2 substrate
0,363  0,004  Antispirochetal
0,372  0,014  Melanin inhibitor
0,388  0,031  Interleukin 2 agonist
0,371  0,015  UGT2B7 substrate
0,379  0,024  Antineoplastic (endocrine cancer)
0,357  0,006  Aldose reductase substrate
0,365  0,016  Antiviral (Influenza)
0,370  0,021  RNA-directed DNA polymerase inhibitor
0,355  0,013  Genotoxic
0,350  0,009  Antihelmintic (Nematodes)
0,345  0,005  Adenylate kinase inhibitor
0,349  0,012  Antineoplastic antimetabolite
0,366  0,031  Sodium/bile acid cotransporter inhibitor
0,336  0,003  Antidote, heavy metal
0,345  0,013  Acaricide
0,333  0,005  Glutamate dehydrogenase inhibitor
0,337  0,010  Alkylator
0,341  0,018  Tyrosine 3 hydroxylase inhibitor
0,337  0,014  Monophenol monooxygenase inhibitor
0,424  0,102  Apoptosis agonist
0,322  0,002  Lysophosphatidic acid 2 receptor antagonist
0,356  0,038  Proliferative diseases treatment
0,329  0,011  Insulin sensitizer
0,349  0,033  UGT1A6 substrate
0,333  0,017  DNA methyltransferase I inhibitor
0,320  0,004  UGT2B10 substrate
0,336  0,021  Antihypotensive
0,354  0,038  Cardiotonic
0,320  0,005  Choleretic
0,331  0,016  Restenosis treatment
0,320  0,005  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,321  0,007  Antiviral (Poxvirus)
0,346  0,034  Angiogenesis stimulant
0,333  0,022  Hepatoprotectant
0,336  0,024  UGT1A4 substrate
0,386  0,083  Antibacterial
0,315  0,015  Bone formation stimulant
0,304  0,004  Carbamoyl phosphate synthetase inhibitor
0,331  0,031  5 Hydroxytryptamine uptake stimulant
0,341  0,044  DNA damaging
0,323  0,029  Septic shock treatment
0,295  0,002  Prostaglandin agonist
0,309  0,021  Diabetic retinopathy treatment
0,312  0,025  Antimutagenic
0,287  0,000  Lysophosphatidic acid receptor 3 agonist
0,297  0,010  UDP-glucose 4-epimerase inhibitor
0,386  0,100  Antiarthritic
0,289  0,004  Antirickettsial
0,303  0,019  Interferon gamma antagonist
0,360  0,077  Toll-Like receptor agonist
0,285  0,003  Anticholelithogenic
0,359  0,078  CYP2C9 substrate
0,301  0,022  Antiacne
0,303  0,027  DNA methylase inhibitor
0,286  0,011  Cell wall synthesis inhibitor
0,281  0,006  Antifungal (Cryptococcus)
0,286  0,014  Renal failure treatment
0,312  0,040  Chemopreventive
0,313  0,044  Vascular (periferal) disease treatment
0,274  0,005  Raynaud's phenomenon treatment
0,301  0,032  Growth hormone agonist
0,322  0,054  Antioxidant
0,274  0,008  Antiviral (CMV)
0,382  0,117  Antineoplastic (solid tumors)
0,270  0,005  Keratolytic
0,271  0,006  Calcium antagonist
0,269  0,004  Phenylalanine 4-hydroxylase inhibitor
0,311  0,049  Tumour necrosis factor alpha release inhibitor
0,261  0,001  Lysophosphatidic acid receptor 1 agonist
0,264  0,004  Arachidonic acid antagonist
0,262  0,004  Adenylate cyclase stimulant
0,270  0,012  Uterine stimulant
0,300  0,043  Antiparasitic
0,262  0,004  Interferon agonist
0,259  0,004  Toll-Like receptor 2 agonist
0,279  0,025  Neurotrophic factor enhancer
0,267  0,014  Carcinogenic, group 1
0,319  0,067  Antiischemic
0,259  0,007  Alcohol dehydrogenase inhibitor
0,342  0,090  GABA C receptor rho-3 antagonist
0,256  0,005  Antiviral (Influenza B)
0,312  0,062  CYP2C19 substrate
0,320  0,071  CYP2D6 substrate
0,253  0,004  Sphingomyelinase inhibitor
0,275  0,027  Antiviral (Herpes)
0,307  0,059  FMO3 substrate
0,249  0,005  Sphingosine 1-phosphate receptor 4 antagonist
0,260  0,016  Cholesterol synthesis inhibitor
0,283  0,039  UDP-glucuronosyltransferase substrate
0,261  0,017  UGT2B9 substrate
0,247  0,006  Photosensitizer
0,265  0,024  Skin whitener
0,242  0,001  Glucose-6-phosphate isomerase inhibitor
0,303  0,062  Antidiabetic (type 2)
0,260  0,022  Cystic fibrosis treatment
0,281  0,043  Antiarrhythmic
0,238  0,001  Lysophosphatidic acid 3 receptor antagonist
0,288  0,055  Superoxide dismutase inhibitor
0,236  0,004  Neuraminidase (influenza) inhibitor
0,242  0,011  Microtubule formation inhibitor
0,235  0,008  Aldehyde dehydrogenase substrate
0,263  0,037  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,233  0,008  Gastric antisecretory
0,270  0,045  Antiviral (HIV)
0,304  0,079  AR expression inhibitor
0,228  0,004  Acyl-CoA dehydrogenase inhibitor
0,240  0,017  Antitussive
0,232  0,009  Coagulant
0,325  0,107  CYP2C19 inhibitor
0,220  0,004  Neuraminidase inhibitor
0,220  0,005  Glutamate decarboxylase inhibitor
0,227  0,016  Aminopeptidase B inhibitor
0,215  0,004  Sphingosine 1-phosphate receptor 4 agonist
0,213  0,003  Prostaglandin E2 agonist
0,256  0,046  Peptidyltransferase inhibitor
0,218  0,008  Vanilloid 1 agonist
0,212  0,003  Ca2+-transporting ATPase inhibitor
0,212  0,005  Leukotriene antagonist
0,214  0,008  Actinic keratosis treatment
0,219  0,013  Cyclooxygenase 3 inhibitor
0,208  0,004  Ornithine decarboxylase inhibitor
0,249  0,047  UGT1A1 substrate
0,232  0,030  Antiviral (Influenza A)
0,209  0,008  Sphingosine 1-phosphate receptor 5 antagonist
0,298  0,102  Inflammatory Bowel disease treatment
0,247  0,050  Platelet adhesion inhibitor
0,217  0,021  Catenin beta inhibitor
0,206  0,010  NADH dehydrogenase inhibitor
0,224  0,028  Antiviral (Ebola)
0,262  0,067  Heart failure treatment
0,202  0,011  Selectin antagonist
0,195  0,005  Paget's disease treatment
0,191  0,002  Prostaglandin EP2 agonist
0,204  0,015  UGT2B1 substrate
0,192  0,005  Histone deacetylase SIRT1 stimulant
0,192  0,005  Histone deacetylase stimulant
0,213  0,027  Antifungal enhancer
0,193  0,007  Ornithine carbamoyltransferase inhibitor
0,227  0,042  Lipocortins synthesis antagonist
0,232  0,046  Antianginal
0,189  0,005  UGT2B11 substrate
0,186  0,004  Sphingosine 1-phosphate receptor agonist
0,202  0,020  GABA C receptor agonist
0,209  0,028  Antianemic
0,201  0,020  Excitatory amino acid transporter EAAC1 inhibitor
0,223  0,043  Antianorexic
0,218  0,038  Antipruritic
0,228  0,049  CYP2B6 inhibitor
0,255  0,078  Flavin-containing monooxygenase substrate
0,203  0,026  Neurotrophic factor
0,179  0,003  Mannosidase inhibitor
0,207  0,032  ATPase inhibitor
0,182  0,008  GST T1-1 substrate
0,196  0,023  Retinoprotector
0,175  0,004  Alpha-mannosidase inhibitor
0,176  0,004  Aconitate hydratase inhibitor
0,256  0,084  Renal disease treatment
0,226  0,055  Antihelmintic
0,174  0,003  Sphingosine 1-phosphate receptor 1 agonist
0,184  0,013  Folate antagonist
0,278  0,108  Transcription factor NF kappa B inhibitor
0,194  0,024  Ferrochelatase inhibitor
0,194  0,023  Antibacterial (Helicobacter pylori)
0,233  0,064  Anticonvulsant
0,184  0,017  Contraceptive female
0,222  0,056  Pneumotoxic
0,182  0,017  GABA C receptor antagonist
0,241  0,077  Antiprotozoal (Leishmania)
0,175  0,011  Toll-Like receptor 4 antagonist
0,171  0,008  Interleukin 5 antagonist
0,216  0,055  Myocardial ischemia treatment
0,208  0,048  Thrombolytic
0,168  0,008  Antiviral (Rhinovirus)
0,186  0,026  Antiprotozoal (Trichomonas)
0,201  0,042  Aldehyde oxidase substrate
0,165  0,007  Glutamate release inhibitor
0,165  0,008  Lanosterol 14 alpha demethylase inhibitor
0,181  0,023  Growth stimulant
0,174  0,019  Sphingosine 1-phosphate receptor 2 antagonist
0,166  0,011  Antimetabolite
0,193  0,039  Pancreatic disorders treatment
0,250  0,096  Insulysin inhibitor
0,234  0,082  Acute neurologic disorders treatment
0,181  0,030  Cell adhesion inhibitor
0,165  0,014  Electrolyte absorption antagonist
0,223  0,073  Antiviral (West Nile virus)
0,154  0,004  Interferon inducer
0,193  0,045  Antineoplastic (bone cancer)
0,153  0,006  Glycine receptor agonist
0,153  0,006  Hyperparathyroidism treatment
0,168  0,023  Carbonic anhydrase III inhibitor
0,177  0,032  Movement disorders treatment
0,161  0,017  GABA C receptor rho-1 antagonist
0,166  0,022  HDL-cholesterol increasing
0,156  0,013  Acetylcholine release stimulant
0,163  0,020  Chronic obstructive bronchitis treatment
0,159  0,018  Myasthenia Gravis treatment
0,149  0,009  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,236  0,095  Transcription factor STAT3 inhibitor
0,151  0,012  Glutathione S-transferase inhibitor
0,187  0,048  UGT2B15 substrate
0,180  0,041  Allergic rhinitis treatment
0,143  0,004  1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor
0,159  0,020  Creatine kinase inhibitor
0,158  0,019  Prolactin inhibitor
0,148  0,011  Restless leg syndrome treatment
0,152  0,015  Transcription factor NF kappa B stimulant
0,153  0,017  Anabolic
0,164  0,031  Chelator
0,159  0,027  Constipation treatment
0,183  0,051  Acute respiratory distress syndrome (ARDS) treatment
0,136  0,005  Sphingosine 1-phosphate receptor 3 agonist
0,145  0,013  Aminopeptidase I inhibitor
0,142  0,013  Antiprotozoal activity enhancer
0,133  0,004  Anesthetic inhalation
0,179  0,050  Hexokinase inhibitor
0,134  0,008  Beta adrenoreceptor antagonist
0,148  0,022  Carbonic anhydrase XIII inhibitor
0,155  0,030  Anticataract
0,142  0,016  Hematopoietic
0,129  0,005  Prostaglandin F2 alpha antagonist
0,153  0,029  Antiviral (Papilloma)
0,128  0,005  Sphingosine 1-phosphate receptor 1 antagonist
0,131  0,008  Peroxisome proliferator-activated receptor alpha agonist
0,126  0,005  Sphingosine kinase inhibitor
0,133  0,012  Prostaglandin EP2 antagonist
0,122  0,005  Gaucher disease treatment
0,207  0,092  Free radical scavenger
0,123  0,007  Leukotriene B4 antagonist
0,143  0,027  Antifungal (Pneumocystis)
0,141  0,026  Arylamine N-Acetyltransferase substrate
0,122  0,007  Beta 1 adrenoreceptor antagonist
0,187  0,073  Nitric oxide antagonist
0,119  0,005  Glucosylceramidase inhibitor
0,125  0,011  Sphingosine 1-phosphate receptor antagonist
0,122  0,009  Antiviral (Herpesvirus 3, Human)
0,122  0,009  Estrogen-related receptor beta agonist
0,126  0,013  Na+ K+ transporting ATPase inhibitor
0,178  0,067  Liver fibrosis treatment
0,117  0,006  Phosphoglycerate kinase inhibitor
0,124  0,013  Biliverdin reductase inhibitor
0,138  0,028  Electron transport complex I inhibitor
0,153  0,044  Cathepsin H inhibitor
0,163  0,054  Hemostatic
0,146  0,038  SULT1A1 substrate
0,116  0,008  Antimycoplasmal
0,111  0,004  Adenosine deaminase inhibitor
0,157  0,051  Toll-Like receptor antagonist
0,111  0,005  Thromboxane synthase inhibitor
0,161  0,055  SULT1A3 substrate
0,130  0,025  ErbB-3 antagonist
0,125  0,020  Antifungal (Candida)
0,122  0,018  Vanilloid agonist
0,142  0,038  Shock treatment
0,111  0,007  Glutamate (mGluR6) antagonist
0,113  0,010  GABA B receptor agonist
0,201  0,098  Antineoplastic (lymphocytic leukemia)
0,107  0,005  Fumarate hydratase inhibitor
0,124  0,023  Cell adhesion molecule inhibitor
0,249  0,148  Toll-Like receptor 7 agonist
0,121  0,020  Peroxisome proliferator-activated receptor gamma agonist
0,106  0,006  Nitric oxide donor
0,221  0,121  Lipoxygenase inhibitor
0,102  0,001  Prostaglandin F2 alpha agonist
0,108  0,008  Purinergic P2Y antagonist
0,115  0,016  Argininosuccinate synthase inhibitor
0,158  0,059  Antiprotozoal (Coccidial)
0,137  0,039  Caspase 3 inhibitor
0,163  0,068  Neuropathy treatment
0,145  0,051  Nav1.3 sodium channel blocker
0,139  0,044  Carcinogenic, group 2B
0,228  0,134  Caspase 3 stimulant
0,123  0,029  Thioredoxin inhibitor
0,098  0,004  Leukotriene C antagonist
0,143  0,050  Adenylate cyclase inhibitor
0,135  0,043  TRPA1 agonist
0,111  0,019  Amidase inhibitor
0,101  0,009  Oleamide hydrolase inhibitor
0,100  0,008  Beta 2 adrenoreceptor antagonist
0,193  0,101  Nitric-oxide synthase stimulant
0,116  0,025  Antileprosy
0,157  0,066  Pulmonary hypertension treatment
0,117  0,026  Histidine decarboxylase inhibitor
0,103  0,013  Antitreponemal
0,098  0,009  Sphingosine 1-phosphate receptor 3 antagonist
0,107  0,018  Ribonucleoside-diphosphate reductase inhibitor
0,108  0,019  Ribonucleotide reductase inhibitor
0,197  0,109  Antineoplastic (liver cancer)
0,121  0,033  Androgen antagonist
0,129  0,041  Protease inhibitor
0,173  0,086  Antieczematic atopic
0,180  0,093  VEGF expression inhibitor
0,113  0,027  Tocolytic
0,097  0,012  Thromboxane antagonist
0,094  0,009  Sphingosine 1-phosphate receptor 5 agonist
0,088  0,004  Neuraminidase (Influenza A) inhibitor
0,100  0,016  Vanilloid 4 agonist
0,227  0,144  Antineoplastic (osteosarcoma)
0,097  0,015  Beta 3 adrenoreceptor antagonist
0,113  0,032  Topoisomerase II alpha inhibitor
0,216  0,136  Metabolic disease treatment
0,093  0,014  Autotaxin inhibitor
0,115  0,037  Tourette's syndrome treatment
0,089  0,011  Thromboxane A2 antagonist
0,102  0,025  GABA aminotransferase inhibitor
0,088  0,011  Sphingosine kinase 2 inhibitor
0,081  0,004  Calcium-sensing receptor antagonist
0,110  0,034  Antidote, mercury
0,109  0,034  Carbonic anhydrase VI inhibitor
0,106  0,031  Cathepsin G inhibitor
0,101  0,026  Leukotriene synthesis inhibitor
0,146  0,071  Lipid peroxidase inhibitor
0,119  0,045  Bronchodilator
0,077  0,004  Prostaglandin EP4 agonist
0,128  0,055  Menstruation disorders treatment
0,204  0,132  Transcription factor STAT inhibitor
0,138  0,067  Interleukin 1 antagonist
0,071  0,002  Carbonic anhydrase VIII inhibitor
0,071  0,002  Carbonic anhydrase X inhibitor
0,138  0,069  Psychosexual dysfunction treatment
0,071  0,003  Lysophosphatidic acid 1 receptor antagonist
0,080  0,012  Epithelial sodium channel blocker
0,144  0,076  Antidiabetic (type 1)
0,148  0,080  Protein-tyrosine phosphatase inhibitor
0,074  0,006  Membrane dipeptidase inhibitor
0,092  0,025  Elastase 1 inhibitor
0,092  0,025  Antidote, organophosphates
0,103  0,036  ATPase (Vacuolar H+) inhibitor
0,080  0,013  Lipocortins synthesis agonist
0,070  0,004  Leukotriene C4 antagonist
0,136  0,071  Farnesoid X receptor antagonist
0,155  0,090  Male reproductive disfunction treatment
0,098  0,034  Glycine receptor antagonist
0,143  0,078  MAP kinase kinase 4 inhibitor
0,088  0,024  Phospholipase D inhibitor
0,112  0,052  Sulfotransferase substrate
0,098  0,038  Adrenaline agonist
0,103  0,043  Bile acid receptor antagonist
0,077  0,017  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,122  0,062  Protein-tyrosine phosphatase 1B inhibitor
0,066  0,006  Hypoxanthine phosphoribosyltransferase inhibitor
0,130  0,070  Antihemorrhagic
0,066  0,007  Sphingosine kinase 1 inhibitor
0,066  0,007  Guanylate cyclase inhibitor
0,122  0,064  Proteasome inhibitor
0,095  0,038  Porphobilinogen synthase inhibitor
0,062  0,005  Purinergic P2Y12 antagonist
0,061  0,004  Prostacyclin agonist
0,065  0,008  GABA uptake inhibitor
0,119  0,063  Interleukin 8 antagonist
0,058  0,002  Vitamin D receptor agonist
0,089  0,034  Narcotic antagonist
0,078  0,023  MDM2 inhibitor
0,080  0,025  Exportin-1 inhibitor
0,060  0,005  Prostaglandin D2 agonist
0,104  0,051  MAP kinase kinase 1 inhibitor
0,102  0,049  Phosphodiesterase 6D inhibitor
0,084  0,031  Protein kinase C alpha inhibitor
0,079  0,028  Protease 3C (Human rhinovirus) inhibitor
0,057  0,006  Uridine phosphorylase inhibitor
0,064  0,013  Retinoid X receptor agonist
0,108  0,058  Nav1.1 sodium channel blocker
0,105  0,056  Antischistosomal
0,126  0,077  Nav1.2 sodium channel blocker
0,056  0,007  Sodium-dependent vitamin C transporter 2 inhibitor
0,052  0,004  Calcium-independent phospholipase A2 inhibitor
0,129  0,082  Nav1.6 sodium channel blocker
0,087  0,041  Antibiotic
0,051  0,007  HMG CoA reductase inhibitor
0,137  0,093  GABA C receptor rho-2 antagonist
0,058  0,014  Thymidine kinase inhibitor
0,095  0,051  Aminoacyl-tRNA synthetase inhibitor
0,065  0,021  Pregnane X receptor antagonist
0,052  0,009  Cholesterol absorption inhibitor
0,055  0,012  Arginase inhibitor
0,187  0,145  Neuropeptide Y2 antagonist
0,070  0,028  Carbonic anhydrase VB inhibitor
0,070  0,029  Maillard reaction inhibitor
0,081  0,042  Lipase inhibitor
0,042  0,002  Thromboxane agonist
0,077  0,038  Peroxisome proliferator-activated receptor gamma antagonist
0,092  0,054  Antiviral (Hepatitis A)
0,076  0,037  Glucagon-like peptide 1 agonist
0,057  0,019  Microtubule stabilization
0,047  0,009  ATP citrate lysase inhibitor
0,041  0,003  Isoleucine-tRNA ligase inhibitor
0,127  0,090  Mannose-6-phosphate isomerase inhibitor
0,221  0,184  Calcium channel activator
0,044  0,006  Elastase 3B inhibitor
0,044  0,006  Elastase 2B inhibitor
0,044  0,006  Elastase 3A inhibitor
0,080  0,043  CDC25A inhibitor
0,039  0,003  Thromboxane A2 agonist
0,115  0,078  Antiprotozoal (Amoeba)
0,039  0,004  Calcium-dependent phospholipase A2 inhibitor
0,045  0,010  Purinergic P2T antagonist
0,050  0,014  Kainate receptor agonist
0,051  0,016  Beta adrenoreceptor agonist
0,089  0,054  Granulocyte macrophage colony stimulating factor agonist
0,059  0,025  Phosphorylase inhibitor
0,053  0,019  Geranyltranstransferase inhibitor
0,056  0,022  Cholesterol esterase inhibitor
0,146  0,112  Neurotensin receptor agonist
0,056  0,024  Equilibrative nucleoside transport protein inhibitor
0,072  0,040  Female sexual dysfunction treatment
0,036  0,004  Neuraminidase (Influenza B) inhibitor
0,053  0,022  Cytokine production stimulant
0,033  0,001  Mannitol 2-dehydrogenase inhibitor
0,035  0,004  Ileal bile acid transport inhibitor
0,048  0,017  Calcitonin receptor agonist
0,063  0,032  Cathepsin D inhibitor
0,071  0,041  SULT2A1 substrate
0,199  0,169  Antineoplastic (brain cancer)
0,094  0,065  Interleukin 1 beta converting enzyme inhibitor
0,119  0,090  Cytokine production inhibitor
0,185  0,156  Prostate cancer treatment
0,133  0,105  Heat shock protein 70 antagonist
0,045  0,017  Nicotinic acid receptor agonist
0,031  0,004  Toll-Like receptor 8 agonist
0,039  0,013  Methionyl aminopeptidase 1 inhibitor
0,055  0,028  Carbonic anhydrase XIV inhibitor
0,160  0,134  Antiamyloidogenic
0,063  0,037  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,048  0,022  GABA B receptor antagonist
0,038  0,013  Leukotriene B4 receptor 1 antagonist
0,043  0,019  Vesicle monoamine transporter inhibitor
0,200  0,175  Multiple sclerosis treatment
0,032  0,008  Vanilloid 2 agonist
0,058  0,033  Adenine nucleotide translocase inhibitor
0,053  0,030  Bombesin 2 receptor antagonist
0,100  0,077  Protein kinase C gamma inhibitor
0,032  0,009  Toll-Like receptor 4 agonist
0,126  0,104  Thiol protease inhibitor
0,099  0,078  Cystathionine beta-synthase inhibitor
0,047  0,025  HIV-1 protease inhibitor
0,032  0,010  Hedgehog signaling activator
0,155  0,134  MAP kinase kinase 5 inhibitor
0,036  0,015  Glutamate (mGluR3) agonist
0,028  0,008  Vitamin D receptor antagonist
0,041  0,021  Glutamate (mGluR8) agonist
0,033  0,013  Lysine carboxypeptidase inhibitor
0,061  0,042  Cannabinoid CB1 receptor agonist
0,038  0,019  Peroxisome proliferator-activated receptor delta agonist
0,033  0,014  Prostaglandin EP4 antagonist
0,140  0,121  Diabetic nephropathy treatment
0,031  0,012  Sodium/glucose cotransporter 2 inhibitor
0,081  0,062  Antiviral (Dengue virus)
0,051  0,032  Plasminogen activator inhibitor antagonist
0,035  0,017  Cholesterol ester transfer protein antagonist
0,023  0,005  Methylmalonyl-CoA mutase inhibitor
0,029  0,012  Thymidine kinase (Herpes simplex virus 1) inhibitor
0,029  0,012  Sodium/glucose cotransporter 1 inhibitor
0,038  0,021  Ceramide glucosyltransferase inhibitor
0,031  0,014  Leukotriene D4 antagonist
0,063  0,046  Antiemphysemic
0,047  0,030  Adenylate cyclase 1 inhibitor
0,050  0,034  Squalene epoxidase inhibitor
0,020  0,004  Carbonic anhydrase XI inhibitor
0,028  0,013  Sodium/glucose cotransporter inhibitor
0,076  0,060  Antineoplastic antibiotic
0,056  0,041  Acetyl-CoA transferase 2 inhibitor
0,097  0,082  DOPA decarboxylase inhibitor
0,035  0,020  Squalene synthetase inhibitor
0,039  0,024  Renin inhibitor
0,064  0,050  Hypercalcemia treatment
0,052  0,037  Vanilloid 2 antagonist
0,024  0,010  Excitatory amino acid transporter 3 inhibitor
0,039  0,025  Vanilloid 3 antagonist
0,032  0,019  Plasmepsin I inhibitor
0,062  0,049  Calcium channel P-type blocker
0,072  0,059  SULT1A2 substrate
0,022  0,009  Apical sodium codependent bile acid transporter inhibitor
0,034  0,022  Prostacyclin antagonist
0,019  0,007  Purinergic P2Y1 agonist
0,021  0,009  Antibiotic Anthracycline-like
0,060  0,049  Beta 2 adrenoreceptor agonist
0,051  0,041  Heparanase inhibitor
0,025  0,016  Excitatory amino acid transporter 2 inhibitor
0,198  0,189  Calpain 2 inhibitor
0,046  0,038  Metalloproteinase-3 inhibitor
0,032  0,023  GABA transporter 3 inhibitor
0,056  0,048  Cathepsin E inhibitor
0,057  0,049  Potassium channel intermediate-conductance Ca-activated blocker
0,039  0,032  Plasmepsin II inhibitor
0,066  0,059  Calcium channel L-type blocker
0,172  0,164  Amyotrophic lateral sclerosis treatment
0,056  0,049  Purinergic P2X1 antagonist
0,035  0,028  Glutamate (mGluR3) antagonist
0,035  0,029  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,086  0,079  Xanthine oxidase inhibitor
0,108  0,102  DNA repair enzyme inhibitor
0,051  0,045  Angiotensin-converting enzyme inhibitor
0,020  0,015  Retinoid X beta receptor antagonist
0,053  0,047  Postcoital contraceptive
0,036  0,031  Retinoid X receptor antagonist
0,062  0,057  Carbonic anhydrase VA inhibitor
0,034  0,029  Antibiotic Aminoglycoside-like
0,027  0,023  Purinergic P2Y15 antagonist
0,017  0,012  Telomerase stimulant
0,020  0,016  Corticosteroid-like
0,155  0,151  Antineoplastic (renal cancer)
0,016  0,013  G-protein-coupled receptor 120 agonist
0,024  0,022  Thyroid hormone agonist
0,020  0,018  Leukotriene B4 receptor 2 antagonist
0,024  0,022  Urotensin II agonist
0,010  0,009  Calcineurin inhibitor
0,052  0,051  Immunoglobulin Fc receptor antagonist
0,021  0,020  Retinoic acid receptor agonist
0,039  0,039  Glutamate (mGluR4) antagonist

